Potential Contribution of Preoperative Neoadjuvant Concurrent Chemoradiation Therapy on Margin-Negative Resection in Borderline Resectable Pancreatic Cancer

Background Margin-negative pancreatectomy provides only chance to cure pancreatic cancer. However, borderline resectable pancreatic cancer (BRPCa) has the risk of incomplete palliative resection. Materials and Methods We retrospectively reviewed 32 patients with BRPCa who underwent a pancreatectomy...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of gastrointestinal surgery 2012-03, Vol.16 (3), p.509-517
Hauptverfasser:	Kang, Chang Moo, Chung, Yong Eun, Park, Jeong Youp, Sung, Jin Sil, Hwang, Ho Kyoung, Choi, Hye Jin, Kim, Hyunki, Song, Si Young, Lee, Woo Jung
Format:	Artikel
Sprache:	eng
Schlagworte:	Adenocarcinoma - pathology Adenocarcinoma - therapy Antineoplastic Agents - therapeutic use Cancer therapies Chemoradiotherapy Female Follow-Up Studies Gastroenterology Humans Male Medical schools Medicine Medicine & Public Health Middle Aged Neoadjuvant Therapy Neoplasm Staging Oncology Original Article Pancreatectomy Pancreatic cancer Pancreatic Neoplasms - pathology Pancreatic Neoplasms - therapy Preoperative Care - methods Radiation therapy Retrospective Studies Surgery Treatment Outcome University colleges
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!